Journal
MOLECULAR ASPECTS OF MEDICINE
Volume 76, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.mam.2020.100890
Keywords
Gasdermin; Inflammasome; Innate immunity; Pyroptosis; Pore-forming protein; Anti-tumor immunity; Immunotherapy
Funding
- NIH/NIAID grant at Harvard Medical School [1R01AI139914]
- Boston Children's Hospital
Ask authors/readers for more resources
Innate immunity enables host defense against pathogens and endogenous danger through inflammasomes, which are supramolecular complexes that recognize the threats and activate the immune response. Inflammasome activation often leads to pyroptosis, a highly inflammatory and lytic form of cell death, as a means of killing infected cells and releasing IL-1 family cytokines that communicate with other cells. Dysregulated inflammasome signaling results in a wide range of immune disorders including gout, sepsis, and hepatitis. Discovered as a direct killer molecule in pyroptosis, gasdermin D (GSDMD) is a pore-forming protein that represents a novel family with diverse cellular functions and pathological roles. This review summarizes current opinions in the biological mechanisms and therapeutic values of the GSDM family, particularly of GSDMD. Detailed mechanisms of auto inhibition and pore formation by the GSDM family are presented, followed by a brief summary of the progress in the development of GSDM-targeting therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available